Publications by authors named "Davide Franceschini"

Claim this Profile
T
Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database.
Giovanni Leuzzi, Federica Sabia, Claudia Proto, Giuseppe Lo Russo, Monica Ganzinelli, Davide Franceschini

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where is clinical research in radiation oncology going? a snapshot from Lombardy, Italy-a study endorsed by AIRO Lombardia.
Mattia Zaffaroni, Maria Giulia Vincini, Stefano Arcangeli, Alessandra Cocchi, Agostina De Stefani, Davide Franceschini

Clin Transl Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC Study.
Alessio Bruni, Davide Franceschini, Beatrice Marini, Stefano Vagge, Patrizia Ciammella

Clin Lung Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter Study.
Davide Franceschini, Paolo Ghirardelli, Patricia Frrokaj, Nicolaus H Andratschke, Luca Nicosia

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Exposure Related to Adjuvant Radiotherapy in Patients Affected by Thymoma: A Dosimetric Comparison of Photon or Proton Intensity-Modulated Therapy.
Antonio Marco Marzo, Luca Cozzi, Davide Franceschini, Luca Dominici, Ruggero Spoto

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.
Stefania Gori, Fiorenza De Rose, Antonella Ferro, Alessandra Fabi, Catia Angiolini, Davide Franceschini

Cancer Treat Rev· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiation Therapy for Oligoprogressive Pleural Mesothelioma: Fine-Tuning the Optimal Doses.
Paolo Ghirardelli, Gianluca Costantino, Davide Franceschini, Elisa Villa, Annamaria Guaineri

Pract Radiat Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study.
Valerio Nardone, Alessio Bruni, Davide Franceschini, Beatrice Marini, Stefano Vagge

Radiol Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR).
Ciro Franzese, Veronica Vernier, Marco Badalamenti, Raffaella Lucchini, Sara Stefanini, Davide Franceschini

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung Lesions.
Davide Franceschini, Mauro Loi, Antonio Marco Marzo, Luca Dominici, Ruggero Spoto

Diseases· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort.
Paolo Borghetti, Giorgio Facheris, Patrizia Ciammella, Marco Galaverni, Lorenzo Granello, Davide Franceschini

Clin Lung Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light?
Sabrina Rossi, Arianna Pagliaro, Angelica Michelini, Pierina Navarria, Elena Clerici, Davide Franceschini

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR).
Ciro Franzese, Veronica Vernier, Davide Franceschini, Tiziana Comito, Pierina Navarria

J Cancer Res Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study).
Tiziana Comito, Maria Massaro, Maria Ausilia Teriaca, Ciro Franzese, Davide Franceschini

Curr Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group.
Giulia Marvaso, Federico Mastroleo, Giulia Corrao, Mattia Zaffaroni, Maria Giulia Vincini, Davide Franceschini

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Letter to the Editor regarding "Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis".
Armando De Virgilio, Andrea Costantino, Bianca Maria Festa, Giuseppe Mercante, Davide Franceschini

J Cancer Res Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors.
Davide Franceschini, Maria Ausilia Teriaca, Luciana Di Cristina, Veronica Vernier, Lorenzo Lo Faro

Br J Radiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study.
Luca Nicosia, Davide Franceschini, Francesca Perrone-Congedi, Alessandro Molinari, Marianna Alessandra Gerardi, Marzia Franceschini

Clin Transl Radiat Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk.
Ciro Franzese, Stefano Tomatis, Sofia Paola Bianchi, Marco Pelizzoli, Maria Ausilia Teriaca, Davide Franceschini

Curr Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform.
Marta Scorsetti, Pierina Navarria, Luca Cozzi, Elena Clerici, Luisa Bellu, Davide Franceschini

Radiat Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study.
Pierina Navarria, Federico Pessina, Giuseppe Minniti, Ciro Franzese, Beatrice Marini, Davide Franceschini

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current treatment approaches for brain metastases in //-positive non-small-cell lung cancer.
Sabrina Rossi, Arianna Marinello, Arianna Pagliaro, Davide Franceschini, Pierina Navarria

Expert Rev Anticancer Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study.
Salvatore Cozzi, Alessio Bruni, Maria Paola Ruggieri, Paolo Borghetti, Vieri Scotti, Davide Franceschini

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors.
Antonella Fogliata, Sara Parabicoli, Lucia Paganini, Giacomo Reggiori, Francesca Lobefalo, Davide Franceschini

Radiat Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360).
Tiziana Comito, Mauro Loi, Ciro Franzese, Elena Clerici, Davide Franceschini

Curr Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis